John S. Owen
John S. Owen publishes mostly in Molecular Biology, Immunology and Endocrinology, Diabetes and Metabolism, on topics such as Cholesterol and Lipid Metabolism, Peroxisome Proliferator-Activated Receptors and Atherosclerosis and Cardiovascular Diseases.
- World rank
- #1,321,578 of 7,710,434 ranked researchers
- Rank in United States
- #419,654 of 1,627,098
- Works
- 40
- Citations
- 1.4k
- Citations per work
- 36.0
What does John S. Owen research?
John S. Owen's work is mostly in Medicine (26%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1742.0%
- Life Sciences1331.6%
- Health Sciences1126.4%
- Medicine1126.4%
- 1Molecular Biology19% of their works
- 2Immunology12% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Surgery9% of their works
- 5Oncology5% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Cholesterol and Lipid Metabolism
- Peroxisome Proliferator-Activated Receptors
- Atherosclerosis and Cardiovascular Diseases
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Protein Kinase Regulation and GTPase Signaling
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Hormonal and reproductive studies
- Drug Transport and Resistance Mechanisms
Which keywords describe John S. Owen's research?
The keywords of their largest research topics: Atherosclerosis, Diabetes, Inflammation, Metabolism, Cholesterol, Obesity, Nuclear Receptors and Transcriptional Regulation.
- Reactive Oxygen Species
- Protein Kinases
- Multidrug Resistance
- ATP-dependent Transporters
- Insulin Resistance
- Cardiovascular Disease
- PPARs
- Metabolic Syndrome
- Transcriptional Regulation
- Obesity
- Metabolism
- Diabetes
- Atherosclerosis
- Inflammation
- Cholesterol
- Nuclear Receptors
- LXR
- SREBP
- Peroxisome Proliferator-Activated Receptors
- Immune Response
- Oxidized LDL
- Hormone Therapy
- Neutrophil Extracellular Traps
- Ras Signaling
- Testosterone
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Atherosclerosis113 topics
- Diabetes93 topics
- Inflammation93 topics
- Metabolism92 topics
- Cholesterol82 topics
- Obesity72 topics
- Nuclear Receptors62 topics
- Transcriptional Regulation62 topics
- LXR51 topic
- Metabolic Syndrome52 topics
- SREBP51 topic
- PPARs41 topic
- Peroxisome Proliferator-Activated Receptors41 topic
- Cardiovascular Disease31 topic
- Immune Response31 topic
- Insulin Resistance31 topic
- Oxidized LDL31 topic
- ATP-dependent Transporters21 topic
- Hormone Therapy21 topic
- Multidrug Resistance21 topic
- Neutrophil Extracellular Traps21 topic
- Protein Kinases21 topic
- Ras Signaling21 topic
- Reactive Oxygen Species21 topic
- Testosterone21 topic
Where does John S. Owen work?
John S. Owen's main affiliation in the publication record is Wake Forest University, United States.
How many publications and citations does John S. Owen have?
OpenAlex counts 40 works and 1,440 citations for John S. Owen, an h-index of 13, ranking #1,321,578 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named John S. Owen
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John S. Owen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.